Literature DB >> 19382874

HIV-1 superinfection in an HIV-2-infected woman with subsequent control of HIV-1 plasma viremia.

Huldrych F Günthard1, Milo Huber, Herbert Kuster, Cyril Shah, Jörg Schüpbach, Alexandra Trkola, Jürg Böni.   

Abstract

A human immunodeficiency virus type 2 (HIV-2)-infected woman experienced asymptomatic superinfection with HIV-1 subtype AG. She did not have cross-neutralizing autologous HIV-1 antibodies before and shortly after HIV-1 superinfection. This evidence supports a mechanism other than cross-neutralizing antibodies for the mild course of HIV-1 infection in this woman.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19382874     DOI： 10.1086/598987

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  11 in total

1.  Potent intratype neutralizing activity distinguishes human immunodeficiency virus type 2 (HIV-2) from HIV-1.

Authors:  Gülsen Ozkaya Sahin; Birgitta Holmgren; Zacarias da Silva; Jens Nielsen; Salma Nowroozalizadeh; Joakim Esbjörnsson; Fredrik Månsson; Sören Andersson; Hans Norrgren; Peter Aaby; Marianne Jansson; Eva Maria Fenyö
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Control of simian immunodeficiency virus SIVmnd-1 RNA plasma viremia after coinfection or superinfection with SIVmnd-1 in SIVmnd-2-infected mandrills and vice versa.

Authors:  Florian Liégeois; Delphine Verrier; Edward Greenwood; Fabian Schmidt; Jonathan Heeney; François Rouet
Journal:  J Virol       Date:  2012-02       Impact factor: 5.103

3.  A Multiplex PCR Approach for Detecting Dual Infections and Recombinants Involving Major HIV Variants.

Authors:  Pierre Cappy; Fabienne De Oliveira; Marie Gueudin; Elodie Alessandri-Gradt; Jean-Christophe Plantier
Journal:  J Clin Microbiol       Date:  2016-02-24       Impact factor: 5.948

4.  Identification of HIV superinfection in seroconcordant couples in Rakai, Uganda, by use of next-generation deep sequencing.

Authors:  Andrew D Redd; Aleisha Collinson-Streng; Craig Martens; Stacy Ricklefs; Caroline E Mullis; Jordyn Manucci; Aaron A R Tobian; Ethan J Selig; Oliver Laeyendecker; Nelson Sewankambo; Ronald H Gray; David Serwadda; Maria J Wawer; Stephen F Porcella; Thomas C Quinn
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

5.  Human immunodeficiency virus type 2 infections in Austria.

Authors:  Ninon Taylor; Jan Marco Kern; Wolfgang Prammer; Alois Lang; Bernhard Haas; Martin Gisinger; Robert Zangerle; Alexander Egle; Richard Greil; Hannes Oberkofler; Josef Eberle
Journal:  Wien Klin Wochenschr       Date:  2014-01-18       Impact factor: 1.704

6.  The rates of HIV superinfection and primary HIV incidence in a general population in Rakai, Uganda.

Authors:  Andrew D Redd; Caroline E Mullis; David Serwadda; Xiangrong Kong; Craig Martens; Stacy M Ricklefs; Aaron A R Tobian; Changchang Xiao; Mary K Grabowski; Fred Nalugoda; Godfrey Kigozi; Oliver Laeyendecker; Joseph Kagaayi; Nelson Sewankambo; Ronald H Gray; Stephen F Porcella; Maria J Wawer; Thomas C Quinn
Journal:  J Infect Dis       Date:  2012-06-05       Impact factor: 5.226

7.  Validation for clinical use of a novel HIV-2 plasma RNA viral load assay using the Abbott m2000 platform.

Authors:  Ming Chang; Geoffrey S Gottlieb; Joan A Dragavon; Stephen L Cherne; Donna L Kenney; Stephen E Hawes; Robert A Smith; Nancy B Kiviat; Papa Salif Sow; Robert W Coombs
Journal:  J Clin Virol       Date:  2012-07-24       Impact factor: 3.168

8.  Frequency of subtype B and F1 dual infection in HIV-1 positive, Brazilian men who have sex with men.

Authors:  Ana Carolina Soares de Oliveira; Rodrigo Pessôa de Farias; Antonio Charlys da Costa; Mariana Melillo Sauer; Katia Cristina Bassichetto; Solange Maria Santos Oliveira; Priscilla Ramos Costa; Claudia Tomiyama; Helena Tomoko Iwashita Tomiyama; Ester Cerdeira Sabino; Esper Georges Kallas; Sabri Saeed Sanabani
Journal:  Virol J       Date:  2012-09-29       Impact factor: 4.099

9.  Multiple HIV-1 infections with evidence of recombination in heterosexual partnerships in a low risk Rural Clinical Cohort in Uganda.

Authors:  Deogratius Ssemwanga; Frederick Lyagoba; Nicaise Ndembi; Billy N Mayanja; Natasha Larke; Shuyi Wang; Joshua Baalwa; Carolyn Williamson; Heiner Grosskurth; Pontiano Kaleebu
Journal:  Virology       Date:  2011-01-15       Impact factor: 3.616

10.  The efficiency of Vpx-mediated SAMHD1 antagonism does not correlate with the potency of viral control in HIV-2-infected individuals.

Authors:  Hangxing Yu; Shariq M Usmani; Alexandra Borch; Julia Krämer; Christina M Stürzel; Mohammad Khalid; Xuehua Li; Daniela Krnavek; Marchina E van der Ende; Albert D Osterhaus; Rob A Gruters; Frank Kirchhoff
Journal:  Retrovirology       Date:  2013-03-05       Impact factor: 4.602
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.